Watch CBS News

FDA approves generic EpiPen

The FDA has approved the first generic rival to EpiPen. The self-injecting device used to treat potentially life-threatening allergic reactions has faced a number of issues in recent years, including shortages and notoriously high prices. The new generic copy will be sold by Teva Pharmaceuticals. Anna Werner reports.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.